Skip to main content
Vital Chemtech Limited logo

Vital Chemtech Limited — Investor Relations & Filings

Ticker · VITAL ISIN · INE0L4K01016 LEI · 335800ILC78PRID95F06 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 151 across all filing types
Latest filing 2026-06-01 Earnings Release
Country IN India
Listing National Stock Exchange of India VITAL

About Vital Chemtech Limited

https://www.vitalgroup.co.in/

Vital Chemtech Limited specializes in the production of phosphorus derivatives and specialty chemicals. The core product range includes Phosphorus Trichloride, Phosphorus Oxychloride, and Phosphorus Pentachloride, which function as essential intermediates for the agrochemical, pharmaceutical, and polymer sectors. The organization operates advanced manufacturing facilities equipped with modern technology to ensure high-purity output and adherence to international quality standards. Its technical capabilities extend to the development of customized chemical solutions and process optimization through dedicated research and development. By focusing on efficient production cycles and technical expertise, the company supports diverse industrial applications requiring precise chemical formulations and reliable supply chain integration.

Recent filings

Filing Released Lang Actions
Press Release
Earnings Release Classification · 95% confidence The document is a press release addressed to the stock exchange under SEBI LODR Regulation 30, announcing audited financial results for Q4 FY26 and FY26 with summary tables and highlights. It provides key performance metrics (revenue, EBITDA, PAT, margins, EPS) and commentary but does not include full financial statements or a detailed interim report. This matches an Earnings Release. FY 2026
2026-06-01 English
Copy of Newspaper Publication
Earnings Release Classification · 85% confidence The document is a formal intimation under SEBI LODR Regulation 47 enclosing the newspaper advertisement of the company’s audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. It includes actual financial result tables (total income, profit before tax, EPS, etc.) published in the “Financial Express”. This is not a full annual report or MD&A, but a public announcement of periodical financial results (i.e., an earnings release). Therefore it falls under the “Earnings Release” category. FY 2026
2026-05-30 English
Outcome of Board Meeting
Regulatory Filings Classification · 82% confidence The document is a formal submission to the National Stock Exchange under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing (1) the outcome of a Board meeting, (2) appointment of cost auditors, and (3) audited standalone and consolidated financial results for the quarter and year ended March 31, 2026 along with the audit report and declaration. It is not the full annual report (10-K), nor merely an earnings release (ER), nor a proxy, dividend, or capital change notice. It is a regulatory compliance filing announcing financial results and related audit documents to the stock exchange. Under our taxonomy, this falls into the catch-all “Regulatory Filings” category (RNS).
2026-05-29 English
Appointment
Interim / Quarterly Report Classification · 72% confidence The document is a composite SEBI LODR filing to the National Stock Exchange of India. It contains: 1) the outcome of a Board meeting held on 29 May 2026 approving the audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026; 2) the submission of those audited financial results, including statements of assets & liabilities, cash flows, and the unmodified audit report; and 3) a declaration by the Managing Director pursuant to Reg 33(3)(d) certifying that the statutory auditors issued an unmodified opinion. The filing attaches the actual financial statements and audit report rather than merely announcing their publication. It therefore constitutes a comprehensive short-period financial report (quarter/year‐end) under SEBI regulations, not just a high-level earnings release or a simple announcement. This aligns with our “Interim / Quarterly Report (IR)” category, which covers filings that include substantive financial statements for periods shorter than a full fiscal year (here Q4) and related year-end results. FY 2026
2026-05-29 English
Outcome of Board Meeting
Regulatory Filings Classification · 85% confidence The document is a compliance submission to the stock exchange under SEBI LODR Regulations, announcing the outcome of the Board meeting, approval of audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, submission of those results and audit report, declaration by the company, and the appointment of a cost auditor. It does not itself contain the detailed financial data or full report tables – these are enclosures or attachments – and reads as a regulatory announcement. Therefore, it best fits the Regulatory Filings (RNS) category.
2026-05-29 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings Classification · 65% confidence The document is a regulatory compliance letter submitted to the stock exchange and audit committee under SEBI regulation 31(4) confirming no additional encumbrances on promoter shares during FY 2025-26. It is neither a financial report nor an announcement of voting, dividends, or M&A activity, but a miscellaneous SEBI declaration. It falls under Regulatory Filings (RNS) as a fallback for miscellaneous compliance submissions.
2026-05-25 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.